German Chemical Firm Bayer Makes $62B Offer for Monsanto

German drug and chemicals company Bayer AG says it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto Company.
Bayer said Monday that the all-cash offer values Monsanto shares at $122 each. It said in a statement that the acquisition “would be a compelling opportunity to create a global agriculture leader, while reinforcing Bayer as a life-science company with a deepened position in a long-term growth industry.”
Bayer had said on Thursday that its executives met recently with their Monsanto counterparts “to privately discuss a negotiated acquisition” of the specialist in genetically modified crop seeds.
Monsanto is headquartered in St. Louis, Missouri.
To Read The Full Story

Become a Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.

Become a Print + Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.

Renew Print + Web Subscription
Click “Renew Subscription” below to begin the process of renewing your subscription.
Are you already a subscriber?
Click "Sign In" to log in!
